Foghorn Therapeutics (FHTX) Upgraded to Buy: Here's Why

Foghorn Therapeutics (FHTX) has been upgraded to a Zacks Rank #2 (Buy), driven by an upward trend in its earnings estimates. The Zacks Consensus Estimate for FHTX's fiscal year 2025 EPS, currently projected at -$1.17, has increased by 1.5% over the past three months. This upgrade places FHTX in the top 20% of Zacks-covered stocks based on earnings estimate revisions, indicating a positive earnings outlook and potential for near-term stock price appreciation due to the strong correlation between earnings revisions and stock movements, often influenced by institutional investors.

Analysis

Foghorn Therapeutics (FHTX) has been upgraded to a Zacks Rank #2 (Buy), a quantitative rating driven by positive momentum in sell-side analyst earnings estimates. This upgrade places the company in the top 20% of stocks covered by the service based on this metric. Specifically, the Zacks Consensus Estimate for the fiscal year ending December 2025 has improved by 1.5% over the past three months. However, it is critical to note that the underlying forecast remains a net loss of $1.17 per share for that year, with no projected year-over-year change. The bullish signal is therefore not based on current or near-term profitability, but rather on the improving sentiment among analysts regarding the company's future earnings potential. The thesis presented is that such positive estimate revisions often precede near-term stock price appreciation, as institutional investors adjust their valuation models and trigger buying activity.

Key Decisions for Investors

• The upgrade signals positive momentum and may present a tactical opportunity for near-term price appreciation, driven by the shift in analyst sentiment.
• Investors should weigh this positive momentum signal against the company's fundamental profile, which includes a projected loss of $1.17 per share in fiscal 2025.
• It is crucial to monitor subsequent earnings estimate revisions, as the entire basis for this bullish rating is dependent on the continuation of this positive trend.